Status: current, Defined. Date: 31-Jan 2011. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3019151000168111 | Optimark 6.62 g/20 mL injection, 20 mL syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 3019161000168113 | Optimark (gadoversetamide 6.62 g / 20 mL) injection, 1 x 20 mL syringe (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Optimark 6.62 g/20 mL injection, 20 mL syringe | Is a | trade product pack | true | Inferred relationship | Some | ||
| Optimark 6.62 g/20 mL injection, 20 mL syringe | Is a | gadoversetamide 6.62 g/20 mL injection, 20 mL syringe | true | Inferred relationship | Some | ||
| Optimark 6.62 g/20 mL injection, 20 mL syringe | has TPUU | Optimark 6.62 g/20 mL injection, 20 mL syringe | true | Inferred relationship | Some | 1 | |
| Optimark 6.62 g/20 mL injection, 20 mL syringe | has TP | Optimark | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Optimark 6.62 g/20 mL injection, 20 mL syringe | Is a | True | Optimark 6.62 g/20 mL injection, 20 mL syringe | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR